Skip to main content
# Title Research Member Research Year
121 Role of 18F-FDG PET/CT in the Detection of Ovarian Cancer Recurrence in the Setting of Elevated Tumor Markers. Dr. Yasser Gaber Ali Abdelhafez 2015
122 Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques Dr. Moamen Mohamed Omran Moustafa Aly 2015
123 Intravenous Fluorouracil versus
Oral Capecitabine: Postoperative
Chemoradiation for Gastric Cancer
Prof. Hamza Abbas Hamza Mohammed 2015
124 Concurrent Boost with Adjuvant Breast Hypofractionated Radiotherapy and Toxicity Assessment Dr. Alia Mohamed Ali Attia 2015
125 18F-FDG PET/CT Outperforms Contrast Enhanced CT in the Diagnosis of Peritoneal Metastases from Ovarian Tumors. Dr. Yasser Gaber Ali Abdelhafez 2015
126 Comparison of Breast Sequential and Simultaneous Integrated Boost Using the Biologically Effective Dose Volume Histogram (BEDVH) Dr. Moamen Mohamed Omran Moustafa Aly 2015
127 Chemoradiation Compared to Surgery Alone in Patients With Non-Metastatic Esophageal Carcinoma Prof. Mohamed Ibrahim Mohamed El-Sayed 2015
128 18F-FDG PET/CT Outperforms Contrast Enhanced CT in the Diagnosis of Peritoneal Metastases from Ovarian Tumors. Dr. Yasser Gaber Ali Abdelhafez 2015
129 Trimodality bladder-sparing approach versus radical cystectomy for invasive bladder cancer
Prof. Mostafa El-Sayed Abdalones Mohamed 2014
130 Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer Dr. Moamen Mohamed Omran Moustafa Aly 2014